A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes

Παρόμοια τεκμήρια

• A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites
  ανά: Slingluff, Craig L., κ.ά.
  Έκδοση: (2015)
• Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens
  ανά: Slingluff, Craig L., κ.ά.
  Έκδοση: (2008)
• Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
  ανά: Meneveau, Max O, κ.ά.
  Έκδοση: (2021)
• Comparative Immunogenicity of Trivalent Influenza Vaccine Administered by Intradermal or Intramuscular Route in Healthy Adults
  ανά: Belshe, Robert B., κ.ά.
  Έκδοση: (2007)
• IMMUNOGENICITY FOR CD8+ AND CD4+ T CELLS OF TWO FORMULATIONS OF AN INCOMPLETE FREUND’S ADJUVANT FOR MULTIPEPTIDE MELANOMA VACCINES
  ανά: Slingluff, Craig L., κ.ά.
  Έκδοση: (2010)